Best-in-class solutions, backed by extensive evidence

Doug White joined Polymedco as CEO in 2022, bringing with him a successful track record of building businesses based on innovative healthcare solutions and world class teams.

Throughout his career, Doug has developed strategic and go-to-market plans, and organizations that have successfully commercialized breakthrough products. Doug brings a wealth of experience with a focus on delivering standard of care changing products and solutions that include cervical cancer screening, STI and infectious disease testing, opioid overdose rescue, and colorectal cancer.

Prior to his role at Polymedco, Doug held executive leadership roles at Emergent BioSolutions, Becton Dickinson, OpGen, Bayer, Chiron and other industry leading MedTech companies

Doug earned his bachelor’s degree from Washington College.

Chris Mathews joined Polymedco as CFO in July 2022, overseeing Finance, Human Resources and Information Systems.

Chris built his career in life sciences, spending 15 years with Merial, the animal health division of Sanofi. After leading the integration of Merial into Sanofi in 2012, he relocated to Lyon, France for 5 years as head of FP&A and ultimately head of global business operations-finance.  Following the successful sale of Merial to Boehringer-Ingelheim, Chris joined Medtronic in their Minimally Invasive Therapies Group, ultimately becoming CFO of the $5B Advanced Surgical Instruments operating unit before joining Polymedco.

Chris has earned an MBA from the University of Georgia, as well as CMA (Certified Managerial Account) and CSCP (Certified Supply Chain Professional) designations.

Helen Landicho has served as Polymedco’s senior vice president of regulatory affairs since 2014, bringing over 25 years of experience within Polymedco’s regulatory and business development divisions.

Before joining Polymedco, Helen was the director of regulatory and clinical affairs with Alidex and spent 14 years with the University of Washington Medical Center in various roles within laboratory medicine.

Helen earned her Bachelor of Science degree from the University of Washington and holds certifications in Regulatory Affairs, Project Management, Experimental Design, Total Quality Management and Medical Technology (ASCP).

Angela Davis joined Polymedco as senior vice president of sales in October 2022, bringing over 25 years of healthcare industry experience primarily in commercial leadership roles.

Before joining Polymedco, Angela spent 24 years at Cardinal Health. In her most recent role, Angela served as national vice president of commercial access for the At-Home Solutions business, where she led field sales, payor, and supplier relationships. Prior to that, Angela held positions including national vice president of laboratory services, distributor management, strategic account sales, and operations.

Angela earned her Bachelor of Science degree from The University of Maryland University College.

Tara Pucci has been with Polymedco for over 25 years, serving in a wide variety of roles that have allowed her to gain extensive knowledge of both the company and the diagnostics space as a whole.

In addition to her role on the executive team, Tara has served Polymedco as director of operations and as a marketing manager. Tara earned her bachelors from Boston College, with a concentration in Business Management and Marketing.

Anthony Bercaw joined Polymedco as Vice President of Marketing in April 2023, bringing over 25 years of commercial and marketing experience across the diagnostic and pharmaceutical industries.

Prior to joining Polymedco, Anthony spent over 13 years with Abbott Laboratories’ Point of Care division and 3 years leading Quest Diagnostics’ healthcare professional marketing team. Anthony earned his bachelor’s degree from Ithaca College and his master’s from George Washington University.